Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Cboe UK CHF

Galderma Group AG (GALDZ.XC)

Compare
114.10
+0.16
+(0.14%)
At close: February 21 at 4:19:45 PM GMT

Research Analysis

Revenue vs. Earnings

Revenue 1.06B
Earnings --

Q2'24

Q3'24

0
200M
400M
600M
800M
1B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
No. of Analysts 1--1010
Avg. Estimate 1.17B--4.43B4.94B
Low Estimate 1.17B--4.4B4.91B
High Estimate 1.17B--4.46B5.19B
Year Ago Sales ------4.4B
Sales Growth (year/est) ------12.19%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Jan 1970)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
GALDZ.XC --------
S&P 500 14.59%7.50%10.82%14.15%